HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Endocrine abnormality in paraneoplastic syndrome.

Abstract
Paraneoplastic syndromes denote rare but notable phenomena caused by the tumour mediated release of bioactive substances. Peptide and non-peptide hormone causes are explored with a particular focus on pathogenesis, symptoms, diagnosis and treatment. Early detection and management of paraneoplastic syndromes can improve morbidly and mortality; definitive treatment remains effective surgical or anti-tumour therapies. Pituitary autoimmunity may provide a novel presentation of paraneoplastic syndromes for which further research is warranted.
AuthorsMichael C Onyema, Eftychia E Drakou, Georgios K Dimitriadis
JournalBest practice & research. Clinical endocrinology & metabolism (Best Pract Res Clin Endocrinol Metab) Vol. 36 Issue 3 Pg. 101621 (05 2022) ISSN: 1878-1594 [Electronic] Netherlands
PMID35153144 (Publication Type: Case Reports, Journal Article, Review)
CopyrightCopyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.
Topics
  • Endocrine System Diseases (complications, diagnosis)
  • Humans
  • Neoplasms
  • Paraneoplastic Endocrine Syndromes (diagnosis, etiology, therapy)
  • Paraneoplastic Syndromes (complications, etiology)
  • Pituitary Diseases (complications)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: